Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-13

Clinical Trial Update: Iberdomide Maintenance Therapy in Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Iberdomide as maintenance therapy in adults with multiple myeloma; trial is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • iberdomide (iberdomide)

Snippet

Sponsor: University of Nebraska | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING